Ahrens Investment Partners LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ahrens Investment Partners LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$447
-55.3%
1,0400.0%0.00%
Q2 2022$1,000
-50.0%
1,0400.0%0.00%
-100.0%
Q1 2022$2,000
-33.3%
1,0400.0%0.00%0.0%
Q4 2021$3,0001,0400.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 610,045$2,014,0000.47%
ETF MANAGERS GROUP, LLC 1,814,328$5,987,0000.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,169$238,0000.06%
Bernardo Wealth Planning LLC 27,219$89,0000.03%
Affinity Asset Advisors, LLC 13,285$44,0000.02%
ALGERT GLOBAL LLC 20,778$69,0000.02%
ZEKE CAPITAL ADVISORS, LLC 49,700$164,0000.01%
Founders Capital Management 2,000$18,0000.01%
King Wealth Management Group 16,000$53,0000.01%
Penserra Capital Management LLC 129,252$425,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders